PACAP CLIA Kit
Kurzübersicht für PACAP CLIA Kit (ABIN6199965)
Target
Alle PACAP (ADCYAP1) CLIA Kits anzeigenReaktivität
Nachweismethode
Methodentyp
Detektionsbereich
Applikation
Proben
-
-
Untere Nachweisgrenze
- 6.17 pg/mL
-
Verwendungszweck
- Human Pituitary adenylate cyclase-activating polypeptide (ADCYAP1/PACAP) CLIA Kit is a Competitive CLIA Kit for use with Serum, plasma, tissue homogenates and other biological fluids.
-
Analytische Methode
- Quantitative
-
Sensitivität
- < 2.55 pg/mL
-
-
-
-
Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
-
Plattentyp
- Pre-coated
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
-
Haltbarkeit
- 6 months
-
-
- PACAP (ADCYAP1) (Adenylate Cyclase Activating Polypeptide 1 (Pituitary) (ADCYAP1))
-
Andere Bezeichnung
- ADCYAP1
-
Pathways
- Neurotrophin Signalübertragung, Positive Regulation of Peptide Hormone Secretion, Hormone Activity, cAMP Metabolic Process, Synaptic Membrane, Production of Molecular Mediator of Immune Response, Regulation of G-Protein Coupled Receptor Protein Signaling
Target Alle PACAP (ADCYAP1) CLIA Kits anzeigen
-